CIK: 0001802528 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value ($000): $1,005,884 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AXSM | AXSOME THERAPEUTICS INC | 1,468,983 | $124,291 | 12.4% | $49.79 | +84.7% | COM | 05464T104 |
| NUVL | NUVALENT INC | 1,317,664 | $103,147 | 10.3% | $22.67 | +312.0% | COM | 670703107 |
| SYRE | SPYRE THERAPEUTICS INC | 4,018,101 | $93,541 | 9.3% | $31.80 | -7.8% | COM NEW | 00773J202 |
| APGE | APOGEE THERAPEUTICS INC | 2,048,647 | $92,804 | 9.2% | $22.03 | +131.5% | COM | 03770N101 |
| SRRK | SCHOLAR ROCK HLDG CORP | 1,962,953 | $84,839 | 8.4% | $32.56 | 0.0% | COM | 80706P103 |
| ELVN | ENLIVEN THERAPEUTICS INC | 3,202,798 | $72,063 | 7.2% | $18.66 | +38.9% | COM | 29337E102 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 3,445,813 | $66,056 | 6.6% | $16.55 | +31.4% | COM | 92790C104 |
| ORKA | ORUKA THERAPEUTICS INC | 3,371,922 | $65,382 | 6.5% | $34.30 | -28.9% | COM | 687604108 |
| DNTH | DIANTHUS THERAPEUTICS INC | 2,700,691 | $58,875 | 5.9% | $15.37 | +67.3% | COM | 252828108 |
| COGT | COGENT BIOSCIENCES INC | 6,225,641 | $48,560 | 4.8% | $8.53 | +16.9% | COM | 19240Q201 |
| KNSA | KINIKSA PHARMACEUTICALS INTL | 2,194,341 | $43,404 | 4.3% | $18.73 | +21.8% | ORD SHS CL A | G52694109 |
| DAWN | DAY ONE BIOPHARMACEUTICALS INC | 3,103,448 | $39,321 | 3.9% | $14.27 | -2.5% | COM | 23954D109 |
| — | ASTRIA THERAPEUTICS INC | 3,554,129 | $31,774 | 3.2% | $9.99 | — | COM | 04635X102 |
| ANAB | ANAPTYSBIO INC | 1,816,466 | $24,050 | 2.4% | $24.22 | 0.0% | COM | 032724106 |
| BCAX | BICARA THERAPEUTICS INC | 1,284,169 | $22,370 | 2.2% | $25.50 | -18.4% | COM | 055477103 |
| IKT | INHIBIKASE THERAPEUTICS INC | 6,125,000 | $19,906 | 2.0% | $2.49 | 0.0% | COM NEW | 45719W205 |
| ZBIO | ZENAS BIOPHARMA INC | 1,892,806 | $15,502 | 1.5% | $17.98 | -13.2% | COM | 98937L105 |